HIPEC in patients with primary advanced ovarian cancer: Is there a role? A systematic review of short- and long-term outcomes
Author:
Publisher
Elsevier BV
Subject
Oncology,Surgery
Reference53 articles.
1. Hyperthermic intraperitoneal chemotherapy: rationale and technique;González-Moreno;World J. Gastrointest. Oncol.,2010
2. Pharmacologic rationale for treatments of peritoneal surface malignancy from colorectal cancer;Sugarbaker;World J. Gastrointest. Oncol.,2010
3. Rationale for Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the treatment or prevention of peritoneal carcinomatosis;Detroz;Acta Chir. Belg.,2004
4. Then and now: cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC), a historical perspective;Neuwirth;J. Gastrointest. Oncol.,2016
5. Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: the ICON3 randomised trial;International;Lancet,2002
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Discrepancy between recommendations regarding hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer management: a narrative review;Chinese Clinical Oncology;2024-06
2. Cytoreductive surgery plus hyperthermic intraoperative peritoneal chemotherapy for people with peritoneal metastases from colorectal, ovarian or gastric origin: A systematic review of randomized controlled trials;World Journal of Surgery;2024-04-24
3. Developing a hyperthermic intraperitoneal chemotherapy (HIPEC) gynecologic oncology program: a Canadian experience;International Journal of Gynecologic Cancer;2023-11-27
4. HIPEC for gynaecological malignancies: A last update (Review);Medicine International;2023-05-04
5. Prediction for 2-year mortality of metastatic ovarian cancer patients based on surveillance, epidemiology, and end results database;Frontiers in Surgery;2022-09-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3